Pharmacists in Garnett, Kansas


13 Pharmacists found in Garnett
male pharmacist

Bryce Douglas Dieker


Pharmacist
429 N Maple St, Garnett, KS 66032
785-448-8878    

male pharmacist

Dr. Casey Gene Smith, PHARM. D


Pharmacist
429 N Maple St, Garnett, KS 66032
785-448-6122    

male pharmacist

Dillan Findley, RPH


Pharmacist
429 N Maple St Ste 200, Garnett, KS 66032
785-448-6122    



female pharmacist

Donna Sue Rockers, PHARMD


Pharmacist
429 N Maple St, Garnett, KS 66032
785-448-6122    

male pharmacist

Dr. Douglas Carmichael Hynek, PHARM.D.


Pharmacist
429 N Maple St, Garnett, KS 66032
785-448-6122     785-448-2853

female pharmacist

Janell Stifter, PHARMD


Pharmacist
21289 Se Neosho Rd, Garnett, KS 66032
785-304-3800    

female pharmacist

Jordan Davied, PHARM.D


Pharmacist
429 N Maple St, Garnett, KS 66032
785-448-6122    

male pharmacist

Mr. Kevin Martin Rycheck, R.PH.


Pharmacist
427 S Oak St, Garnett, KS 66032
785-448-6650     785-448-6686

male pharmacist

Mr. Michael William Burns, RPH


Pharmacist
429 N Maple St, Garnett, KS 66032
785-448-6122     785-448-3206

female pharmacist

Miranda Naylor, PHARM.D.


Pharmacist
429 North Maple, Garnett, KS 66032
785-448-6122    

female pharmacist

Dr. Morgan Tichy, PHARMD


Pharmacist
429 N Maple St, Garnett, KS 66032
785-448-6122    

male pharmacist

Dr. Nathan Wiehl, PHARM.D.


Pharmacist
429 N Maple St, Garnett, KS 66032
785-448-6122     785-448-2853

male pharmacist

Ryan Gerald Moore, PHARMD


Pharmacist
429 N Maple St, Garnett, KS 66032
785-448-6122     785-448-2853


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.